Simplex Trading, LLC Gain Therapeutics, Inc. Transaction History
Simplex Trading, LLC
- $175 Billion
- Q2 2025
A detailed history of Simplex Trading, LLC transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 5,657 shares of GANX stock, worth $8,655. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,657
Previous 3,444
64.26%
Holding current value
$8,655
Previous $6,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding GANX
# of Institutions
39Shares Held
4.47MCall Options Held
37.9KPut Options Held
0-
Jones Financial Companies Lllp677KShares$1.04 Million0.0% of portfolio
-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$900,2670.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$866,1780.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA534KShares$817,5580.0% of portfolio
-
Geode Capital Management, LLC Boston, MA290KShares$444,4060.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $18.2M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...